Please confirm that an ethics committee approval has been applied for or granted: Not relevant (see information at the bottom of this page)

Background and Aims SAFIRA (SAFer Injection for Regional Anaesthesia - Medovate Ltd.) is an advanced technology designed to enhance the precision and safety of regional anaesthesia procedures.

Methods As an anaesthetic trainee, I found SAFIRA’s novel pressure sensing needle helpful in proving real-time pressure monitoring feedback, enabling the user to adjust their technique, aiming for optimal needle placement, and reducing the risk of complications, such as intraneural or intravascular injections. With a colour-coded foot pedal or handheld switch system, the user-friendly design of SAFIRA has allowed me to become confident performing various regional anaesthesia procedures with a single operator technique, allowing for quicker, easier and more time efficient procedures.

Results A survey of anaesthetic trainees within QEHKL, as well as a London and Melbourne hospital, showed 74% believed an injection pressure monitoring system should be available in their hospital. In QEHKL, SAFIRA is available, however only 55% of trainees have used it, of which the majority only used it infrequently, either because it is not readily available (29%), or they do not feel confident using it (39%). 48% found SAFIRA user-friendly, however, only 16% found that it saved time. Finally, an overwhelming 71% found SAFIRA helpful in trying to prevent intraneural injection and nerve damage.

Conclusions In conclusion, this abstract offers an overview of a trainee’s experience with SAFIRA, emphasising the journey from initial curiosity, to becoming proficient in utilising its features for safer and more precise injections. As well as underscoring the potential benefits of SAFIRA in enhancing patient safety and improving regional anaesthesia outcomes.